COMMON HOLDER Sample Clauses

COMMON HOLDER. XXXXXXX X. XXXXX /s/ Xxxxxxx X. Xxxxx ADAMAS PHARMACEUTICALS, INC. COUNTERPART SIGNATURE PAGE TO FOURTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT By execution and delivery of this signature page, the undersigned hereby agrees to become a party to that certain Fourth Amended and Restated Investors’ Rights Agreement (the “Rights Agreement”) by and among Adamas Pharmaceuticals, Inc., a Delaware corporation, the Investors (as defined in the Rights Agreement) and the Common Holders (as defined in the Rights Agreement) dated as of June 30, 2011 and is entitled to all of the benefits under and subject to all of the obligations, restrictions and limitations set forth in the Rights Agreement that are applicable to the Investors and/or the Common Holders, as the case may be. This Counterpart Signature Page shall take effect and shall become a part of said Rights Agreement immediately upon execution. COMMON HOLDER: XXXX XXXXXXXXXX /s/ Xxxx Xxxxxxxxxx ADAMAS PHARMACEUTICALS, INC. COUNTERPART SIGNATURE PAGE TO FOURTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT By execution and delivery of this signature page, the undersigned hereby agrees to become a party to that certain Fourth Amended and Restated Investors’ Rights Agreement (the “Rights Agreement”) by and among Adamas Pharmaceuticals, Inc., a Delaware corporation, the Investors (as defined in the Rights Agreement) and the Common Holders (as defined in the Rights Agreement) dated as of June 30, 2011 and is entitled to all of the benefits under and subject to all of the obligations, restrictions and limitations set forth in the Rights Agreement that are applicable to the Investors and/or the Common Holders, as the case may be. This Counterpart Signature Page shall take effect and shall become a part of said Rights Agreement immediately upon execution. INVESTOR: WS INVESTMENT COMPANY, LLC (2011A) By: /s/ WS Investment Company, LLC (2011A) Name: Title: ADAMAS PHARMACEUTICALS, INC. COUNTERPART SIGNATURE PAGE TO FOURTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT By execution and delivery of this signature page, the undersigned hereby agrees to become a party to that certain Fourth Amended and Restated Investors’ Rights Agreement (the “Rights Agreement”) by and among Adamas Pharmaceuticals, Inc., a Delaware corporation, the Investors (as defined in the Rights Agreement) and the Common Holders (as defined in the Rights Agreement) dated as of June 30, 2011 and is entitled to all of the benefits under and sub...
Sample 1Sample 2
AutoNDA by SimpleDocs
COMMON HOLDER s/ Xxxx Xxx Xxxxx Name: Xxxx Xxx Xxxxx Address: [*] Tel: [*] Fax: _____________________
Sample 1
COMMON HOLDER. Sherxxx Xxxx ------------------------------------ Yu-Hua Xxxxx ------------------------------------ Danixx Xxxxx ------------------------------------ Pierxx Xxxx ------------------------------------ Jerrx Xxxx ------------------------------------ Warrxx X. Xxxxxx ------------------------------------ Judixx X. Xxxxxx ------------------------------------ Stuaxx X. Xxxxxx ------------------------------------ Marc X. Xxxxxx ------------------------------------ Franx XxXxxxx ------------------------------------ Alexis Geranois SIGNATURE PAGE TO ABOVENET COMMUNICATION, INC. AMENDED AND RESTATED INVESTORS' RIGHTS AGREEMENT 20 ------------------------------------ Doug Xxxxxxxx ------------------------------------ Jimmx Xxxxx ------------------------------------ Belixxx Xxx ------------------------------------ Kevix Xxxxxxxx ------------------------------------ Kevix Xxxxxxx ------------------------------------ Stepxxx X. Xxxxxx ------------------------------------ Paul Xxxxxx ------------------------------------ Lucixxx Xxxxxx ------------------------------------ Davix Xxxxxx SIGNATURE PAGE TO ABOVENET COMMUNICATION, INC. AMENDED AND RESTATED INVESTORS' RIGHTS AGREEMENT SERIES A PREFERRED STOCK HOLDERS: ------------------------------------ Petex Xxxx ------------------------------------ Pat Xxxx ------------------------------------ Eric X. Xxxx ------------------------------------ Paulx X. Xxxx ------------------------------------ Davix Xxxx ------------------------------------ En-Lei Xxxx ------------------------------------ Ta-Hui Xxxx ------------------------------------ Yi-Ping Xxxxx ------------------------------------ Belixxx Xxx SIGNATURE PAGE TO ABOVENET COMMUNICATION, INC. AMENDED AND RESTATED INVESTORS' RIGHTS AGREEMENT SERIES B PREFERRED STOCK HOLDERS: PETEX XXXX & XAT XX-HXX XXXING TRUST ------------------------------------ ------------------------------------ Eric X. Xxxx ------------------------------------ Paulx X. Xxxx ------------------------------------ Wendx Xx-Hua Xxxx ------------------------------------ Robexx Xxxx ------------------------------------ Teddx Xxxxx ------------------------------------ Sylvxx Xx-Xx Xxxxx TU-TING & TE-FANG XXXXX XXXING TRUST ------------------------------------ ------------------------------------ Jerrx Xxxx ------------------------------------ Gracx Xxx SIGNATURE PAGE TO ABOVENET COMMUNICATION, INC. AMENDED AND RESTATED INVESTORS' RIGHTS AGREEMENT ------------------------------------ Belixxx Xxx ----------------...
Sample 1
COMMON HOLDER. The Zabludowicz Trust By: /s/ Fabio Botterini de Pelosi Name: Fabio Botterini de Pelosi Title: Trustee Address: ##### SIGNATURE PAGE TO THE AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT FOR PALANTIR TECHNOLOGIES INC. IN WITNESS WHEREOF, the parties have executed this Amended and Restated Investors’ Rights Agreement as of the date first above written. COMMON HOLDER: Xxxxx Partners II, L.P. By: Xxxxx Management II, LLC, its General Partner By: /s/ Xxxxx Xxxxx Name: Xxxxx Xxxxx Title: Managing Member Address: ##### SIGNATURE PAGE TO THE AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT FOR PALANTIR TECHNOLOGIES INC. IN WITNESS WHEREOF, the parties have executed this Amended and Restated Investors’ Rights Agreement as of the date first above written. COMMON HOLDER: Xxxxx Partners III, L.P. By: Xxxxx Management III, LLC, its General Partner By: /s/ Xxxxx Xxxxx Name: Xxxxx Xxxxx Title: Managing Member Address: ##### SIGNATURE PAGE TO THE AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT FOR PALANTIR TECHNOLOGIES INC. IN WITNESS WHEREOF, the parties have executed this Amended and Restated Investors’ Rights Agreement as of the date first above written. COMMON HOLDER: Disruptive Technology Solutions LLC By: /s/ Xxxxxxxxx Xxxxx Name: Xxxxxxxxx Xxxxx Title: Officer of its Manager Address: ##### SIGNATURE PAGE TO THE AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT FOR PALANTIR TECHNOLOGIES INC. IN WITNESS WHEREOF, the parties have executed this Amended and Restated Investors’ Rights Agreement as of the date first above written. COMMON HOLDER: Disruptive Technology Solutions III, LLC By: /s/ Xxxxxxxxx Xxxxx Name: Xxxxxxxxx Xxxxx Title: Officer of its Manager Address: ##### SIGNATURE PAGE TO THE AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT FOR PALANTIR TECHNOLOGIES INC. IN WITNESS WHEREOF, the parties have executed this Amended and Restated Investors’ Rights Agreement as of the date first above written. COMMON HOLDER: Advanced Technology Fund, LLC By: /s/ Xxxxxxx Xxxxxxxxx Name: Xxxxxxx Xxxxxxxxx Title: Manager Address: ##### SIGNATURE PAGE TO THE AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT FOR PALANTIR TECHNOLOGIES INC. IN WITNESS WHEREOF, the parties have executed this Amended and Restated Investors’ Rights Agreement as of the date first above written. COMMON HOLDER: Advanced Technology Select Fund VI, LLC By: /s/ Xxxxxxx Xxxxxxxxx Name: Xxxxxxx Xxxxxxxxx Title: Manager Address: ##### SIGNATURE PAGE TO THE AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT FO...
Sample 1
COMMON HOLDER s/ XXXXXXX X. XXXXXXX ------------------------ Xxxxxxx X. Xxxxxxx COMMON HOLDER: /s/ XXXXX X. XXXXXX ------------------------ Xxxxx X. Xxxxxx COMMON HOLDER: /s/ XXXXXXX X. XXXXXX ------------------------ Xxxxxxx X. Xxxxxx COMMON HOLDER: /s/ XXXXXXX XxXXXXXX ------------------------ Xxxxxxx XxXxxxxx COMMON HOLDER: /s/ XXXXXXX XXXXXX ------------------------ Xxxxxxx Xxxxxx COMMON HOLDER: /s/ XXXXX X. XXXXXXXX ------------------------ Xxxxx X. Xxxxxxxx COMMON HOLDER: /s/ XXXXXXX X. XXXXXXXXXX -------------------------- Xxxxxxx X. Xxxxxxxxxx COMMON HOLDER: /s/ XXXXXXXX XXXXXXXX ------------------------ Xxxxxxxx Xxxxxxxx
Sample 1
COMMON HOLDER s/ Ta-Xxx Xxxxx Name: Ta-Xxx Xxxxx Address: [*] Tel: [*] Fax: [*] E-mail: [*] [*] Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. SIGNATURE PAGE TO SHARE TRANSFER AGREEMENT
Sample 1
COMMON HOLDER s/ Kong-Xxx Xxx Name: Kong-Xxx Xxx Address: [*] Tel: [*] Fax: _____________________
Sample 1
AutoNDA by SimpleDocs
COMMON HOLDER. By: /s/ Xxxxx Xxxxx Name: The Xxxxx Xxxxx 2010 Grantor Retained Annuity Trust By: Xxxxx Xxxxx Its: EXHIBIT A INVESTORS Sequoia Capital Growth Fund III Sequoia Capital Franchise Fund Sequoia Capital Franchise Partners Sequoia Capital Growth III Principals Fund Sequoia Capital Growth Partners III Francisco Partners, L.P. Francisco Partners Fund A, L.P. Francisco Partners III, L. P. Francisco Partners Parallel Fund III, L.P. EXHIBIT B COMMON HOLDERS Xxxx X. Xxxxx Xxxx X. Xxxxx Living Trust Xxxxxxx Xxxxxx The Xxxxxxx Xxxxxx 2010 Four Year Grantor Retained Annuity Trust The Xxxxxxx Xxxxxx 2010 Three Year Grantor Retained Annuity Trust
Sample 1

Related to COMMON HOLDER

  • Warrant Holder Not a Shareholder The holding of a Warrant will not constitute the Holder thereof a shareholder of the Company, nor entitle him to any right or interest in respect thereof except as in the Warrant expressly provided.

  • Holder The term “

  • WARRANT HOLDER NOT DEEMED A STOCKHOLDER Except as otherwise specifically provided herein, the Holder, solely in its capacity as a holder of this Warrant, shall not be entitled to vote or receive dividends or be deemed the holder of share capital of the Company for any purpose, nor shall anything contained in this Warrant be construed to confer upon the Holder, solely in its capacity as the Holder of this Warrant, any of the rights of a stockholder of the Company or any right to vote, give or withhold consent to any corporate action (whether any reorganization, issue of stock, reclassification of stock, consolidation, merger, conveyance or otherwise), receive notice of meetings, receive dividends or subscription rights, or otherwise, prior to the issuance to the Holder of the Warrant Shares which it is then entitled to receive upon the due exercise of this Warrant. In addition, nothing contained in this Warrant shall be construed as imposing any liabilities on the Holder to purchase any securities (upon exercise of this Warrant or otherwise) or as a stockholder of the Company, whether such liabilities are asserted by the Company or by creditors of the Company. Notwithstanding this Section 6, the Company shall provide the Holder with copies of the same notices and other information given to the stockholders of the Company generally, contemporaneously with the giving thereof to the stockholders.

  • Holder Not Deemed a Stockholder Except as otherwise specifically provided herein, this Warrant shall not entitle Holder to vote or receive dividends or any other rights of a stockholder of the Company, including, without limitation, any right to vote, give or withhold consent to any corporate action (whether a reorganization, issue of stock, reclassification of stock, consolidation, merger, conveyance or otherwise), receive notice of meetings or receive subscription rights.

  • Warrant Holder Not Shareholder This Warrant does not confer upon the holder hereof any right to vote or to consent or to receive notice as a shareholder of the Company, as such, in respect of any matters whatsoever, or any other rights or liabilities as a shareholder, prior to the exercise hereof as hereinbefore provided.

  • Permitted Transferee 26 Person ......................................................................................26

  • Voting Rights as a Stockholder Subject to the terms of the Insider Letter described in Section 4.4 hereof and except as herein provided, the Initial Stockholders shall retain all of their rights as stockholders of the Company during the Escrow Period, including, without limitation, the right to vote such shares.

  • Additional Stockholders In connection with the issuance of any additional equity securities of the Company to any Person, the Company may permit such Person to become a party to this Agreement and succeed to all of the rights and obligations of a "Stockholder" under this Agreement by obtaining the consent of the holders of a majority of the Common Stockholder Shares and an executed counterpart signature page to this Agreement, and, upon such execution, such Person shall for all purposes be a "Stockholder" party to this Agreement.

  • Permitted Transferees The rights of a Holder hereunder may be assigned (but only with all related obligations as set forth below) in connection with a Transfer of Registrable Securities to a Permitted Transferee of that Holder. Without prejudice to any other or similar conditions imposed hereunder with respect to any such Transfer, no assignment permitted under the terms of this Section 4.4 will be effective unless the Permitted Transferee to which the assignment is being made, if not a Holder, has delivered to the Company a written acknowledgment and agreement in form and substance reasonably satisfactory to the Company that the Permitted Transferee will be bound by, and will be a party to, this Agreement. A Permitted Transferee to whom rights are transferred pursuant to this Section 4.4 may not again transfer those rights to any other Permitted Transferee, other than as provided in this Section 4.4.

  • Founder Shares In April 2021, the Company issued to CCIF Global LLC, a Delaware limited liability company (the “Sponsor”), an aggregate of 4,312,500 Class B ordinary shares of the Company, par value $0.0001 per share, for an aggregate purchase price of $25,000 (the “Founder Shares,” and together with the Class A Shares, collectively, the “Ordinary Shares”), in a private placement exempt from registration under Section 4(a)(2) of the Securities Act of 1933, as amended (the “Act”). No underwriting discounts, commissions, or placement fees have been or will be payable in connection with the purchase of Founder Shares. Except as described in the Registration Statement, none of the Founder Shares may be sold, assigned or transferred by the Sponsor until the earlier of (a) one year following the consummation of the Business Combination, (b) following the consummation of the Business Combination, the last sale price of the Class A Shares equals or exceeds $12.00 per share (as adjusted for share subdivisions, share dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after our initial business combination, and (c) the date following the consummation of the Business Combination on which the Company consummates a liquidation, merger, stock exchange or similar transaction which results in all of the Company’s public shareholders having the right to exchange their Ordinary Shares for cash, securities, or other property. The Founder Shares shall be subject to restrictions on transfer as set forth in the Insider Letters (as defined below). The holders of Founder Shares shall have no right to any liquidating distributions with respect to any portion of the Founder Shares in the event the Company fails to consummate the Business Combination. The holders of the Founder Shares shall not have redemption rights with respect to the Founder Shares. In the event that the Over-allotment Option is not exercised in full, the Sponsor will be required to forfeit such number of Founder Shares such that the Founder Shares then outstanding will comprise 20% of the issued and outstanding Ordinary Shares (but not including any Private Placement Securities (as defined below)) after giving effect to the Offering and exercise, if any, of the Over-allotment Option. The Founder Shares will automatically convert into Class A Shares concurrently with the consummation of the Business Combination on a one-for-one basis, subject to adjustment as described in the Prospectus.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!